Dawei Zhang
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Oncology top 10%
- Viral-associated cancers and disorders
- COVID-19 and healthcare impacts
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Oncology 22
- Viral-associated cancers and disorders 6
- Peptidase Inhibition and Analysis 6
- HER2/EGFR in Cancer Research 3
- Co-authors
- Yuan Mao (14 shared papers)Jin Zhu (11 shared papers)Lin Xiong (11 shared papers)Guofeng Chen (1 shared paper)Chen Zhu (1 shared paper)Yu Wang (1 shared paper)Peng Zhao (1 shared paper)Jingfeng Bi (1 shared paper)
- Journals
- Scientific Reports (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Pathology (2 papers)Clinical Infectious Diseases (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Dawei Zhang
68 papers receiving 1.3k citations
Dawei Zhang's Hit Papers
Peers
Comparison fields: 5 of 112
- Infectious Diseases 313
- Oncology 415
- Neurology 157
- Pathology and Forensic Medicine 169
- Radiology, Nuclear Medicine and Imaging 206
Countries citing papers authored by Dawei Zhang
This map shows the geographic impact of Dawei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Zhang more than expected).
Fields of papers citing papers by Dawei Zhang
This network shows the impact of papers produced by Dawei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Zhang. The network helps show where Dawei Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score Hit paper breakdown → | 2020 | 391 |
| 2 | 2014 | 93 | |
| 3 | 2013 | 83 | |
| 4 | 2011 | 40 | |
| 5 | 2012 | 38 | |
| 6 | 2012 | 37 | |
| 7 | 2014 | 36 | |
| 8 | 2011 | 34 | |
| 9 | 2014 | 32 | |
| 10 | Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma. | 2014 | 27 |
| 11 | 2016 | 27 | |
| 12 | 2016 | 26 | |
| 13 | 2013 | 25 | |
| 14 | 2017 | 23 | |
| 15 | 2012 | 22 | |
| 16 | 2016 | 21 | |
| 17 | 2012 | 20 | |
| 18 | 2020 | 19 | |
| 19 | 2018 | 17 | |
| 20 | 2020 | 16 |
About Dawei Zhang
Dawei Zhang is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Peptidase Inhibition and Analysis (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Neuroblastoma Research and Treatments (5 papers), Glycosylation and Glycoproteins Research (4 papers), Sarcoma Diagnosis and Treatment (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Infectious Diseases (313 citations), Oncology (415 citations), Neurology (157 citations), Pathology and Forensic Medicine (169 citations) and Radiology, Nuclear Medicine and Imaging (206 citations). Dawei Zhang has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yuan Mao, Jin Zhu, Lin Xiong, Guofeng Chen, Chen Zhu, Yu Wang, Peng Zhao, Jingfeng Bi, Lin Tan and Jing Xu. Their work appears in journals such as Scientific Reports, Bioorganic & Medicinal Chemistry Letters, Pathology, Clinical Infectious Diseases and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.